Abstract
Antimicrobial resistance in Neisseria gonorrhoeae is increasing in the Pacific region. The standard antibiotic used in urban Australia is intramuscular ceftriaxone. Isolates with reduced sensitivity are being isolated; however, resistance to ceftriaxone has yet to occur. Continued surveillance of antimicrobial resistance in the pathogen, with communication between clinic and laboratory, is needed to ensure optimal treatment of infection.
Get full access to this article
View all access options for this article.